Archive

The GEMS contribution increase remains at 9.5% after the CMS rejected a further reduction, prompting criticism from public sector unions.

Ebola treatment trials in the DRC need at least $18m in urgent funding to test experimental drugs and strengthen contact tracing.

Healthcare access during protests must be protected, SAMA says, as anti-immigration marches raise safety concerns.

Unsafe cosmetic procedures using unregulated injectables have prompted a national health warning after two patients suffered kidney failure.

Hospital CEO vacancies are raising concerns about governance, accountability and service delivery across the public health system.

Shingrix is set to launch in South Africa, promising better shingles protection. Find out what this means for patients and costs.

Lenacapavir HIV prevention offers twice-yearly PrEP, but trust, access, stigma and continued engagement will determine its impact.

Global HIV treatment gap leaves 8.8 million people without therapy as funding cuts weaken testing, prevention and community-led services.

AI alternatives to animal testing can predict toxicity and organ damage while offering more ethical and human-relevant research methods.

US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.

iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.